Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Winter, A. Alimohammadi, A. Panzenboeck, M. Sibilia, F. Nagel, D. Santer, B. Podesser, S. Alias, M. Frey, I. Lang (Vienna, Austria). Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension. Eur Respir J 2013; 42: Suppl. 57, 482

Member's Comments

No comment yet.

Related content which might interest you: Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Reactive oxygen species production by rat neutrophils in pulmonary arterial hypertension experimental model Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Splenectomy delays thrombus resolution Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models Source: Eur Respir J, 57 (5) 2003271; 10.1183/13993003.03271-2020 Year: 2021 Role of the TrkA receptor in experimental severe pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Myocardial perfusion in patients with pulmonary hypertension of different etiology Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019